A Multicenter Machine Learning-Based Predictive Model of Acute Toxicity in Prostate Cancer Patients Undergoing Salvage Radiotherapy (ICAROS Study)
- PMID: 40647440
- PMCID: PMC12249318
- DOI: 10.3390/cancers17132142
A Multicenter Machine Learning-Based Predictive Model of Acute Toxicity in Prostate Cancer Patients Undergoing Salvage Radiotherapy (ICAROS Study)
Abstract
Background: This study aimed to develop a predictive model for acute gastrointestinal (GI) and genitourinary (GU) toxicity in prostate cancer patients treated with salvage radiotherapy (SRT) post-prostatectomy, using machine learning techniques to identify key prognostic factors.
Methods: A multicenter retrospective study analyzed 454 patients treated with SRT from three Italian radiotherapy centers. Acute toxicity was assessed using Radiation Therapy Oncology Group criteria. Predictors of grade ≥ 2 toxicity were identified through Least Absolute Shrinkage and Selection Operator (LASSO) regression and Classification and Regression Tree (CART) modeling. The analyzed variables included surgical technique, clinical target volume (CTV) to planning target volume (PTV) margins, extent of lymphadenectomy, radiotherapy technique, and androgen-deprivation therapy (ADT).
Results: No patients experienced grade ≥ 4 toxicity, and grade 3 toxicity was below 1% for both GI and GU events. The primary determinant of acute toxicity was the surgical technique. Open prostatectomy was associated with significantly higher grade ≥ 2 GI (41.8%) and GU (35.9%) toxicity compared to laparoscopic/robotic approaches (18.9% and 12.2%, respectively). A CTV-to-PTV margin ≥ 10 mm further increased toxicity, particularly when combined with extensive lymphadenectomy. SRT technique and ADT were additional predictors in some subgroups.
Conclusions: SRT demonstrated excellent tolerability. Surgical technique, CTV-to-PTV margin, and treatment parameters were key predictors of toxicity. These findings emphasize the need for personalized treatment strategies integrating surgical and radiotherapy factors to minimize toxicity and optimize outcomes in prostate cancer patients.
Keywords: LASSO regression; acute toxicity; androgen-deprivation therapy; gastrointestinal toxicity; genitourinary toxicity; machine learning; planning target volume; predictive model; prostate cancer; salvage radiotherapy.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Tomotherapy With Synchrony Fiducial Tracking for Stereotactic Body Radiotherapy in Prostate Cancer: A Single-Center Experience on Toxicity.Cureus. 2025 May 30;17(5):e85083. doi: 10.7759/cureus.85083. eCollection 2025 May. Cureus. 2025. PMID: 40585690 Free PMC article.
-
Refining prognostic stratification in salvage radiotherapy for prostate cancer: A retrospective multicenter cohort study using PSMA-PET and machine learning.Radiother Oncol. 2025 Aug 21:111113. doi: 10.1016/j.radonc.2025.111113. Online ahead of print. Radiother Oncol. 2025. PMID: 40849083
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.Health Technol Assess. 2012;16(41):1-313. doi: 10.3310/hta16410. Health Technol Assess. 2012. PMID: 23127367 Free PMC article.
-
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006019. doi: 10.1002/14651858.CD006019.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054269 Free PMC article.
Cited by
-
The Surgical Imprint: How Operative Trauma May Shape Radiation Tolerance After Prostatectomy.Cancers (Basel). 2025 Aug 18;17(16):2685. doi: 10.3390/cancers17162685. Cancers (Basel). 2025. PMID: 40867315 Free PMC article.
References
-
- Cornford P., van den Bergh R.C.N., Briers E., Van den Broeck T., Brunckhorst O., Darraugh J., Eberli D., De Meerleer G., De Santis M., Farolfi A., et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur. Urol. 2024;86:148–163. doi: 10.1016/j.eururo.2024.03.027. - DOI - PubMed
LinkOut - more resources
Full Text Sources